A new study based on 14 years of Nipah virus infections in Bangladesh—the country hit hardest by the disease—revealed an elevated risk to caregivers, the role of respiratory secretions, and other new clues about what fuels transmission among humans, findings that could help control future outbreaks.

An international group of researchers published its findings today in the New England Journal of Medicine.

Nipah virus, a paramyxovirus spread by bats found throughout South and Southeast Asia, is one of nine World Health Organization (WHO) priority diseases for research and development.

Given its severe respiratory and neurologic symptoms, Nipah virus infections have a high case fatality. There are no treatments or vaccines for the disease, however, which in 2017 landed Nipah on

NIAID

a list of three diseases targeted by the Coalition for Epidemic Preparedness Innovations, a new vaccine partnership that came together in the wake of West Africa’s massive Ebola outbreak.

Read more…

See also:

May 9 N Engl J Med study

May 8 Pasteur Institute press release

May 9 N Engl J Med commentary